[news 2005 -2006]

CIHR Commercial Management Fellow to focus on promising life science technologies at Queen’s, KGH

June 6, 2005

For immediate release

KINGSTON, ON -- PARTEQ Innovations, the technology transfer arm of Queen’s University, is pleased to announce the appointment of Ms. Eileen Dent as a Fellow, Commercialization Management, effective June 6. The one-year position is partially funded by the Canadian Institutes of Health Research (CIHR) and is focused on the commercialization of new technologies arising from research in the life sciences.

Ms. Dent brings more than 10 years of experience in research, development and commercialization of technologies for government and the private sector. She has worked with Biostar Inc., a spinoff company of the University of Saskatchewan’s Vaccine and Infectious Diseases Organization, and Fisher Scientific, and provided research and commercial development expertise to the University of Saskatchewan and the National Research Council. She also founded her own business, Science Synergies Consulting. She is a graduate of Carleton University (BSc), Queen’s University (MSc) and the University of Saskatchewan (MBA).

Reporting to Anne Vivian-Scott, Director of Commercial Development, Ms. Dent will identify, evaluate and manage new intellectual property generated by research in life sciences at Queen’s University and/or Kingston General Hospital.

“We are fortunate to attract a candidate with a broad range of experience along the innovation spectrum,” says Ms. Vivian-Scott. “Ms. Dent’s background in both research and early stage technology development makes her ideally suited to this position.”

The Commercialization Management Grants Program was established to enhance professional development of intellectual property managers, and to assist universities and hospitals in better managing intellectual property arising from health research.

Information:
John P. Molloy, President & CEO
PARTEQ Innovations
613. 533. 2342
www.parteqinnovations.com